FDA recall record

Dexcom Receiver, REF: MT22719, (Black, Pin, Blue), Rx Only, containing software version recall — FDA Z-0929-2020

It has been reported that use of the mobile receiver with software version SW10617 rev 4.0.1.048 have reported: 1. the receiver becoming stuck on…

Class IIclassification
Z-0929-2020official record ID
Feb 12, 2020report date

Recall record at a glance

Official recordZ-0929-2020
CategoryMedical Device Recalls
ClassificationClass II
FDA record statusTerminated
Recalling firmDexcom Inc.
Report dateFeb 12, 2020
Recall initiation dateJul 12, 2019
Quantity112,415 receivers
LocationSan Diego, CA, United States

Official product description

Dexcom Receiver, REF: MT22719, (Black, Pin, Blue), Rx Only, containing software version SW10617 and revision 4.0.1.048 - Product Usage: A non-adjunctive invasive glucose sensor is intended to determine glucose levels, and the direction and rate of change of glucose levels in people with diabetes. The device is indicated to replace information obtained from standard blood glucose monitoring devices to make diabetes-related treatment decisions. The device also provides historical glucose information, facilitating long-term therapy adjustments.

Why the product was recalled

It has been reported that use of the mobile receiver with software version SW10617 rev 4.0.1.048 have reported: 1. the receiver becoming stuck on initialization screen when powering on. This will cause patients not to be able to receive glucose values or alerts; 2. Reinitialization of the receiver without user interaction. If this occurs, the receiver will either reboot and operate normally or require the user to press the Select button on the receiver in order to resume normal operation. In this situation, the user is provided an audio and vibratory alert every 5 minutes. Until the select button is pressed, patients will not receive glucose values or alerts.

Distribution information

US Nationwide distribution.

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.

Medical DeviceMay 20, 2026

Dexcom G7 CGM watchOS App recall — FDA Z-2164-2026

A software defect in which a low-priority file I/O check blocks the higher-priority thread responsible for processing estimated glucose values (EGVs) and trend arrows. When the app is…

Class IIFDA: OngoingDexcom, Inc.
Medical DeviceMay 20, 2026

Dexcom G7 CGM iOS App recall — FDA Z-2163-2026

A software defect in which a low-priority file I/O check blocks the higher-priority thread responsible for processing estimated glucose values (EGVs) and trend arrows. When the app is…

Class IIFDA: OngoingDexcom, Inc.
Medical DeviceMay 20, 2026

Dexcom ONE+ iOS CGM App recall — FDA Z-2165-2026

A software defect in which a low-priority file I/O check blocks the higher-priority thread responsible for processing estimated glucose values (EGVs) and trend arrows. When the app is…

Class IIFDA: OngoingDexcom, Inc.
Medical DeviceSep 10, 2025

Dexcom G7 CGM Android App recall — FDA Z-2446-2025

The affected devices are the Dexcom G7 Continuous Glucose Monitoring System (CGM System) using iOS, watchOS and Android App software (versions 2.8.0 or earlier) and Dexcom ONE+ CGM System…

Class IFDA: OngoingDexcom, Inc.